0001181431-12-003409.txt : 20120120
0001181431-12-003409.hdr.sgml : 20120120
20120120213024
ACCESSION NUMBER: 0001181431-12-003409
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120118
FILED AS OF DATE: 20120120
DATE AS OF CHANGE: 20120120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POWELL MICHAEL
CENTRAL INDEX KEY: 0001202793
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34828
FILM NUMBER: 12538164
MAIL ADDRESS:
STREET 1: C/O SOFINNOVE VENTURE PARTNERS INC
STREET 2: 140 GEARY BLVD 10TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trius Therapeutics Inc
CENTRAL INDEX KEY: 0001356857
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201320630
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DR SUITE 105
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-452-0370
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DR SUITE 105
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
rrd331179.xml
X0304
4
2012-01-18
0
0001356857
Trius Therapeutics Inc
TSRX
0001202793
POWELL MICHAEL
C/O SOFINNOVA VENTURES
2800 SAND HILL ROAD, SUITE 150
MENLO PARK
CA
94025
1
0
0
0
Common Stock
2012-01-18
4
S
0
4300
5.5569
D
115700
I
See Footnote.
Common Stock
2012-01-19
4
S
0
2600
5.6392
D
113100
I
See Footnote.
Common Stock
28
I
See Footnote.
Shares are owned directly by Sofinnova Management VII, L.L.C. ("SV VII LLC"), the general partner of Sofinnova Venture Partners VII, L.P. ("SV VII"), and Michael Powell, a director of the issuer, James Healy and Eric Buatois, the managing members of SV VII LLC (together, the "Managing Members"), may be deemed to have shared voting and dispositive power over the shares owned by SV VII LLC.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SV VII LLC on December 22, 2011, as amended.
Accumulated fractional shares held by SV VII.
Shares are owned directly by SV VII. SV VII LLC, the general partner of SV VII, and the Managing Members, may be deemed to have shared voting and dispositive power over the shares owned by SV VII.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.43 to $5.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (5) and (6) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.60 to $5.69, inclusive
The reporting person disclaims benefical ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
/s/ Nathalie Auber, Attorney-in-Fact for Michael Powell
2012-01-20